Both in Biotechnology
Immunovant vs Adaptive Biotechnologies
Over the past year IMVT returned +23.8% and ADPT returned +54.2%; their daily moves had a correlation of 0.23.
IMVT +23.8% ADPT +54.2%Growth of $1, one year, split-adjusted
| Metric | IMVT | ADPT |
|---|---|---|
| Price | $29.44 | $26.73 |
| Market cap | $6.08B | $4.27B |
| Today | +1.36% | +3.60% |
| 1 month | −8.3% | −0.6% |
| 6 months | +2.7% | +85.2% |
| Year to date | +15.8% | +64.6% |
| 1 year | +23.8% | +54.2% |
| Revenue growth (YoY) | — | +21.5% |
| Gross margin | — | 71.8% |
| Net margin | — | −55.6% |
| P/E (TTM) | — | — |
| Price / sales | — | 13.8× |
| Net cash | $797.8M | $9.4M |
| Dividend yield | — | — |
| Volatility (60d) | 37.1% | 51.6% |
| Short % of float | 21.1% | 10.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).